Epirubicin HCl

Catalog No.S1223 Synonyms: 4'-epidoxorubicin HCl

Epirubicin HCl Chemical Structure

Molecular Weight(MW): 579.98

Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.

Size Price Stock Quantity  
In DMSO USD 160 In stock
USD 70 In stock
USD 120 In stock
USD 270 In stock
Bulk Discount
Bulk Inquiry

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 7 Publications

1 Customer Review

  •  

    Growth inhibitory effects of Epirubicin human pancreatic cancer cells. MiaPaCa-2 cells were plated in triplicates into 48-well plates at a density of 10,000 cells/ml. After 24 hours, complete culture medium was changed into fresh low-serum-containing medium (0.5% FBS) containing DMSO (control) or indicated doses of Epirubicin (Selleckchem). Cell viability 48 hours after treatment was determined by AlamarBlue assay (Invitrogen) according to manufacturer's instructions. Results are expressed as percentages of control, which was arbitrarily assigned 100% viability, and represented as the mean ± standard deviation (SD) of the tripicate wells. 

    Dr. Edita Aksamitiene from Thomas Jefferson University. Epirubicin HCl purchased from Selleck.

Purity & Quality Control

Choose Selective Topoisomerase Inhibitors

Biological Activity

Description Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.
Targets
Topoisomerase [1]
(Cell-free assay)
In vitro

Epirubicin, like doxorubicin, exerts its antitumor effects by complex with DNA, resulting in damage to DNA and interference with the synthesis of DNA, RNA, and proteins. Epirubicin may also affect the integrity and activity of cellular membranes. Maximal cell kill caused by Epirubicin occurs during the S phase of the cell cycle. With higher concentrations effects are also seen in early G2 as well as G1 and M phases. [1] Epirubicin display antineoplastic activity against most cancer cells. Epirubicin is cytotoxic to Hepatoma G2 cells with IC50 of 1.6 μg/mL at 24hr. 1.6 μg/mL Epirubicin induces apoptosis of Hep G2 cells, and higher activity of catalase by 50%, Se-dependent glutathione peroxidase by 110%, Cu, Zn-superoxide dismutase by 172% and Mn-superoxide dismutase by 135%. Epirbicin increases the cellular expression of NADPH-CYP 450 reductase, and reduces GST-π expression. [2]
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MCF-7 cells M2PreGN6fG:2b4jpZ:Kh[XO|YYm= NWLa[FhtS2:vcH;1coQhf2G|IITld5Rm\CCob4KgbZR{KHSxeHnjbZR6KGGpYXnud5QhcHWvYX6gZpJm[XO2IHPhcoNmeiClZXzsd{hOS0ZvNzmsJGlEPTB;MD6yJO69VQ>? M1fCV|k2PDh6MkC=
human PC3 cells NYTLeWM2S3m2b4TvfIlkyqCjc4PhfS=> M{GwXlYh\GG7cx?= NFHSXJNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBRSzNiY3XscJMh[W[2ZYKgOkBl[Xm|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlQ3KM7:TR?= MmSyNlIzPzZ4N{m=
human HCT116 cells NX3qR4U6S3m2b4TvfIlkyqCjc4PhfS=> NHTpNHQ3KGSjeYO= MUjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgOkBl[Xm|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlgzKM7:TR?= NG[5RVYzOjJ5Nk[3PS=>
human Hep3B cells NXSxZlVpS3m2b4TvfIlkyqCjc4PhfS=> MYe2JIRigXN? M4jJUWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmeDOEIHPlcIx{KGGodHXyJFYh\GG7czDifUBOXFRiYYPzZZktKEmFNUC9NE46PiEQvF2= NUDjTZJ2OjJ{N{[2O|k>
human HepG2 cells MXnDfZRwfG:6aXRCpIF{e2G7 NE\TVXo3KGSjeYO= NWrtelg{S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWyR{KgZ4VtdHNiYX\0[ZIhPiCmYYnzJIJ6KE2WVDDhd5NigSxiSVO1NF0yNjZ3IN88US=> NVKzVI5HOjJ{N{[2O|k>
human MCF7/ADR cells MVLDfZRwfG:6aXRCpIF{e2G7 MmfTOkBl[Xm| NXPpXowyS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINz;BSHIh[2WubIOgZYZ1\XJiNjDkZZl{KGK7IF3UWEBie3OjeTygTWM2OD1zLk[1JO69VQ>? MmjoNlIzPzZ4N{m=
human MCF7 cells NYf5Om5rWHKxbHnm[ZJifGmxbjDhd5NigQ>? MnjmOFghcA>? MV\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0{NjdizszN NFuyZlIzOzJ6N{C1Oy=>
NIH/3T3 cells M3rqZnBzd2yrZnXyZZRqd25iYYPzZZk> MljyOFghcA>? NUHKPIo2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDOTWgwO1R|IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUC9OE4zKM7:TR?= MUSyN|I5PzB3Nx?=
human T47D cells MVHQdo9tcW[ncnH0bY9vKGG|c3H5 NWO4[3NxPDhiaB?= M4LzVGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVES3SEBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTRwMzFOwG0> MV:yN|I5PzB3Nx?=
human HepG2 cells M2DtbHBzd2yrZnXyZZRqd25iYYPzZZk> M1nBNlQ5KGh? NFj3SpBCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjldGczKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;ND62JO69VQ>? NXXZZmtSOjN{OEewOVc>
human MDA-MB-231 cells NF22b5RRem:uaX\ldoF1cW:wIHHzd4F6 NVnWbGhbPDhiaB?= NWWwd5FuSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVA:PS54IN88US=> MlS4NlMzQDdyNUe=
human PC3 cells MoGzVJJwdGmoZYLheIlwdiCjc4PhfS=> MXS0PEBp MnjJRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQ{OgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF02NjdizszN NVPMWpRnOjN{OEewOVc>
human A549 cells MnPwVJJwdGmoZYLheIlwdiCjc4PhfS=> M2j3dlQ5KGh? M2LxVGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUW0PUBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTlwNjFOwG0> MXmyN|I5PzB3Nx?=
human DU145 cells NGfxUldRem:uaX\ldoF1cW:wIHHzd4F6 MY[0PEBp MlfrRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCGVUG0OUBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxRTlwOTFOwG0> NW\JU41vOjN{OEewOVc>
human T47D cells MWfDfZRwfG:6aXRCpIF{e2G7 M4rOclUh|ryP NV;4UpFQPDhiaB?= M3nOeGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHQ1P0RiY3XscJMh[XO|ZYPz[YQh[XNiY3jhcodmKGmwIHPlcIwhfmmjYnnsbZR6KGG2IEWgeW0h[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfS=> NUSxSGNFOjN{OEewOVc>
human MCF7 cells MUjDfZRwfG:6aXRCpIF{e2G7 M2\qTlUh|ryP MmjHOFghcA>? MnvxR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyClaHHu[4UhcW5iY3XscEB3cWGkaXzpeJkh[XRiNTD1UUBi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5 NY\sZ|FLOjN{OEewOVc>
human MDA-MB-231 cells NGPvUJFEgXSxdH;4bYPDqGG|c3H5 MlSwOUDPxE1? MXO0PEBp M{PXUGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGS{dXetdoV{cXO2YX70JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYYPz[ZN{\WRiYYOgZ4hidmenIHnuJINmdGxidnnhZoltcXS7IHH0JFUhfU1iYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigQ>? NIXyVIgzOzJ6N{C1Oy=>

... Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot
HIF-1α / GLUT1 / PDK1 ; 

PubMed: 28339028     


The expression of HIF-1α, PDK1 and glycolysis-related proteins GLUT1, LDHA in 435R cells with/without 2-MeOE2.

FOXM1 / Cyclin B1 / PLK; 

PubMed: 21518729     


MCF-7 and MCF-7-EPIR cells were treated with 1µmol/L of epirubicin for 0, 16, 24 and 48 h. At indicated time, cells were collected and analysed by western blotting to determine the protein expression levels of FOXM1, Cyclin B1, PLK and β-tubulin, and by RT-qPCR to determine FOXM1 mRNA transcript levels.

E2F1 / p-p53 / p53 / Caspase-7 ; 

PubMed: 21518729     


U2OS cells were treated for 0 to 24 h with 1µmol/L of epirubicin in the presence or absence of 5mmol/L of caffeine. At indicated time, cells were collected for western blot analysis to determine the protein expression levels of FOXM1, E2F1, P-p53 (ser15), p53, Cleaved caspase 7 and β-tubulin. 

PARP / E2F1 / p-E2F1 / p-MK2 / p-Chk2 ; 

PubMed: 22802261     


Pretreatment with the p38 inhibitor SB203580 prevents epirubicin-induced E2F1 accumulation and its phosphorylation at Serine 364. U2OS cells were either pretreated with 20 μM SB203580 or untreated and 1h later exposed to 1μM epirubicin. At the times indicated at the top of each lane cells were harvested and proteins extracted from lysates. Equal amounts of protein were used for Western blot analysis with the indicated antibodies. Anti-β-tubulin was immunoblotted as a loading control.

28339028 21518729 22802261
Growth inhibition assay
Cell death ; 

PubMed: 24158003     


KMS20 (left panel) and KMS28BM (right panel) cells were treated with 2ME at the indicated doses for 48 h and subjected to FACS analysis as described above.

24158003
In vivo Epirubicin are clinically active against a broad range of tumor types, including breast cancer, malignant lymphomas, soft tissue sarcomas, lung cancer, pleural mesothelioma, gastrointestinal cancer, head and neck cancer, ovarian cancer, prostatic carcinoma, transitional bladder carcinoma and so on. [3] Epirubicin at a dose of 3.5 mg/kg suppresses tumor mass of human breast tumor xenograft R-27 by 74.4 %. [4]

Protocol

Cell Research:[2]
- Collapse
  • Cell lines: Human hepatocellular carcinoma cell Hep G2
  • Concentrations: 0.05-12 μg/mL
  • Incubation Time: 1 days
  • Method: Hep G2 cells (500 cells/well, monolayer) are plated in a 96-well plate. The next day the cells are treated with Epirubicin in the medium. At the end of the incubation periods, 15% volume of MTT dye solution is added. After 1 hr of incubation at 37℃, an equal volume of solubilization/stop solution (dimethylsul-foxide) is added to each well for an additional 1 hr incubation. The absorbance of the reaction solution at 570 nm is recorded.
    (Only for Reference)
Animal Research:[4]
- Collapse
  • Animal Models: Human breast tumor xenograft R-27
  • Formulation: Saline
  • Dosages: 3.5 mg/kg
  • Administration: i.v. every 4 day for 3 times
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 100 mg/mL (172.41 mM)
Water 100 mg/mL warmed (172.41 mM)
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 579.98
Formula

C27H29NO11.HCl
CAS No. 56390-09-1
Storage powder
in solvent
Synonyms 4'-epidoxorubicin HCl

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01740271 Recruiting Drug: Epirubicin Breast Neoplasms AHS Cancer Control Alberta December 2012 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
selleck catalog

Topoisomerase Signaling Pathway Map

Related Topoisomerase Products

  • SCR7 New

    SCR7 is a specific DNA Ligase IV inhibitor, which blocks nonhomologous end-joining (NHEJ). It increases the efficiency of HDR-mediated genome editing up to 19-fold using CRISPR/Cas9 in mammalian cells and mouse embryos.

  • Blasticidin S HCl New

    Blasticidin S HCl is a nucleoside antibiotic isolated from Stretomyces girseochromogenes, and acts as a DNA and protein synthesis inhibitor, used to select transfected cells carrying bsr or BSD resistance genes.

  • LMK-235 New

    LMK-235 is a selective inhibitor of HDAC4 and HDAC5 with IC50 of 11.9 nM and 4.2 nM, respectively.

  • Doxorubicin (Adriamycin) HCl

    Doxorubicin (Adriamycin) HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis in tumor cells.

  • Etoposide

    Etoposide is a semisynthetic derivative of podophyllotoxin, which inhibits DNA synthesis via topoisomerase II inhibition activity.

  • Camptothecin

    Camptothecin is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM in a cell-free assay. Phase 2.

  • Daunorubicin HCl

    Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM in a cell-free assay.

  • SN-38

    SN-38 is an active metabolite of CPT-11, inhibits DNA topoisomerase I, DNA synthesis and causes frequent DNA single-strand breaks.

  • Topotecan HCl

    Topotecan HCl is a topoisomerase I inhibitor for MCF-7 Luc cells and DU-145 Luc cells with IC50 of 13 nM and 2 nM in cell-free assays, respectively.

    Features:Topotecan is a water-soluble derivative of camptothecin.

  • Idarubicin HCl

    Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL in a cell-free assay.

    Features:Idarubicin is a substrate for CYP450 2D6 and 2C9.

Tags: buy Epirubicin HCl | Epirubicin HCl supplier | purchase Epirubicin HCl | Epirubicin HCl cost | Epirubicin HCl manufacturer | order Epirubicin HCl | Epirubicin HCl distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID